Aesica Pharmaceuticals Ltd
Get verified emails for Aesica Pharmaceuticals Ltd employeesAbout Aesica Pharmaceuticals Ltd
Aesica Pharmaceuticals Ltd is a pharmaceutical contract development and manufacturing organisation (CDMO) that provides end-to-end services for both APIs and finished dose forms. Short and clear. Its work covers formulation development for API and finished dose, manufacturing across all scales, and packaging services, with capabilities designed to support customers from development through production.
Aesica Pharmaceuticals Ltd also includes end-to-end capabilities in the design, industrialisation, and manufacture of medical delivery devices, which it says helps simplify the supply chain and increase customer control. That is the point. Aesica serves customers through a partnership approach focused on quality, reliability, and service.
Founded in 2004, Aesica employs approximately 1,300 colleagues across five development and manufacturing sites in the UK, Germany, and Italy, along with an international office in Shanghai and its head office in north London, UK. It is part of the Consort Medical group.
Need to reach the Aesica Pharmaceuticals Ltd team directly? Find verified work emails for every employee with Snov.io
Insights
Updated 31 Aug 2026Aesica Pharmaceuticals Limited appears to operate in pharma manufacturing and services from Newcastle upon Tyne. Short profile. The available materials, though, place it in a Hong Kong listed-company circular rather than as a publicly traded operating issuer itself, and the HKEX circular shows the company was part of a transaction or disclosure that required shareholder attention. The sources do not give enough operating detail to compare product lines, scale, or direct competitors.
Strategic evidence is thin. There are no supplied sources covering expansion plans, pipeline changes, capacity investments, or restructuring, so the clearest reading is that the business was being discussed in a formal capital-markets or governance setting rather than through a day-to-day commercial update. That matters.
Investor and consumer signals are sparse in the supplied materials. The HKEX circular is the only source that points to an investor-facing event, while the Bionity profile simply identifies the company and location, and there is no hiring, earnings, fundraising, or customer sentiment data to support a stronger demand or momentum signal.
Frequently asked questions
Aesica Pharmaceuticals Ltd is headquartered in Sweden.
Aesica Pharmaceuticals Ltd has 1001-5000 employees according to its company profile.
Aesica Pharmaceuticals Ltd operates in the Pharmaceuticals sector. Public valuation figures are not always disclosed for private companies.